ArticleJournal of experimental & clinical cancer research : CR2023

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.

Martin Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.